vs
Side-by-side financial comparison of Clearwater Paper Corp (CLW) and Cardiff Oncology, Inc. (CRDF). Click either name above to swap in a different company.
Clearwater Paper Corp is the larger business by last-quarter revenue ($360.3K vs $243.0K, roughly 1.5× Cardiff Oncology, Inc.). Clearwater Paper Corp runs the higher net margin — -3.6% vs -2969.5%, a 2966.0% gap on every dollar of revenue. On growth, Cardiff Oncology, Inc. posted the faster year-over-year revenue change (62.0% vs -4.7%). Over the past eight quarters, Cardiff Oncology, Inc.'s revenue compounded faster (8.9% CAGR vs -96.8%).
Clearwater Paper Corporation is an American pulp and paperboard manufacturer. The company was created on December 9, 2008, via a spin-off from Potlatch Corporation and is headquartered in Spokane, Washington.
CLW vs CRDF — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $360.3K | $243.0K |
| Net Profit | $-12.8K | $-7.2M |
| Gross Margin | -0.2% | — |
| Operating Margin | — | -3221.0% |
| Net Margin | -3.6% | -2969.5% |
| Revenue YoY | -4.7% | 62.0% |
| Net Profit YoY | -103.2% | 38.8% |
| EPS (diluted) | — | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $360.3K | — | ||
| Q4 25 | $386.4M | $243.0K | ||
| Q3 25 | $399.0M | $120.0K | ||
| Q2 25 | $391.8M | $121.0K | ||
| Q1 25 | $378.2M | $109.0K | ||
| Q4 24 | $387.1M | $150.0K | ||
| Q3 24 | $393.3M | $165.0K | ||
| Q2 24 | $344.4M | $163.0K |
| Q1 26 | $-12.8K | — | ||
| Q4 25 | $38.3M | $-7.2M | ||
| Q3 25 | $-53.3M | $-11.3M | ||
| Q2 25 | $2.7M | $-13.9M | ||
| Q1 25 | $-6.3M | $-13.4M | ||
| Q4 24 | $199.1M | $-11.8M | ||
| Q3 24 | $5.8M | $-11.9M | ||
| Q2 24 | $-25.8M | $-11.8M |
| Q1 26 | -0.2% | — | ||
| Q4 25 | 4.5% | — | ||
| Q3 25 | 4.7% | — | ||
| Q2 25 | 11.0% | — | ||
| Q1 25 | 9.7% | — | ||
| Q4 24 | 3.8% | — | ||
| Q3 24 | 7.7% | — | ||
| Q2 24 | -0.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | -3221.0% | ||
| Q3 25 | -13.9% | -9978.3% | ||
| Q2 25 | 2.5% | -12212.4% | ||
| Q1 25 | -1.1% | -13194.5% | ||
| Q4 24 | -4.0% | -8381.3% | ||
| Q3 24 | -0.3% | -7637.0% | ||
| Q2 24 | -13.6% | -7696.3% |
| Q1 26 | -3.6% | — | ||
| Q4 25 | 9.9% | -2969.5% | ||
| Q3 25 | -13.4% | -9381.7% | ||
| Q2 25 | 0.7% | -11523.1% | ||
| Q1 25 | -1.7% | -12324.8% | ||
| Q4 24 | 51.4% | -7858.0% | ||
| Q3 24 | 1.5% | -7184.8% | ||
| Q2 24 | -7.5% | -7225.8% |
| Q1 26 | — | — | ||
| Q4 25 | $2.36 | $-0.11 | ||
| Q3 25 | $-3.30 | $-0.17 | ||
| Q2 25 | $0.17 | $-0.21 | ||
| Q1 25 | $-0.38 | $-0.20 | ||
| Q4 24 | $11.87 | $-0.22 | ||
| Q3 24 | $0.35 | $-0.25 | ||
| Q2 24 | $-1.55 | $-0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.5M | $58.3M |
| Total DebtLower is stronger | $361.1M | — |
| Stockholders' EquityBook value | $813.8M | $45.4M |
| Total Assets | $1.6B | $61.9M |
| Debt / EquityLower = less leverage | 0.44× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $36.5M | — | ||
| Q4 25 | $30.7M | $58.3M | ||
| Q3 25 | $34.4M | $60.6M | ||
| Q2 25 | $46.7M | $71.0M | ||
| Q1 25 | $44.0M | $79.9M | ||
| Q4 24 | $79.6M | $91.7M | ||
| Q3 24 | $35.5M | $57.7M | ||
| Q2 24 | $39.6M | $60.3M |
| Q1 26 | $361.1M | — | ||
| Q4 25 | $346.8M | — | ||
| Q3 25 | $337.0M | — | ||
| Q2 25 | $330.1M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $283.4M | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.1B | — |
| Q1 26 | $813.8M | — | ||
| Q4 25 | $825.3M | $45.4M | ||
| Q3 25 | $783.0M | $48.8M | ||
| Q2 25 | $836.8M | $58.6M | ||
| Q1 25 | $836.6M | $70.9M | ||
| Q4 24 | $854.6M | $82.9M | ||
| Q3 24 | $664.6M | $49.4M | ||
| Q2 24 | $658.6M | $52.4M |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $61.9M | ||
| Q3 25 | $1.6B | $63.8M | ||
| Q2 25 | $1.6B | $75.7M | ||
| Q1 25 | $1.6B | $84.8M | ||
| Q4 24 | $1.7B | $97.2M | ||
| Q3 24 | $2.5B | $62.9M | ||
| Q2 24 | $2.5B | $66.1M |
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.42× | — | ||
| Q3 25 | 0.43× | — | ||
| Q2 25 | 0.39× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.33× | — | ||
| Q3 24 | 1.73× | — | ||
| Q2 24 | 1.74× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-6.0M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $5.0M | $-6.0M | ||
| Q3 25 | $34.0M | $-10.8M | ||
| Q2 25 | $-28.2M | $-8.3M | ||
| Q1 25 | $1.5M | $-12.8M | ||
| Q4 24 | $-35.1M | $-10.3M | ||
| Q3 24 | $16.2M | $-10.5M | ||
| Q2 24 | $21.1M | $-9.2M |
| Q1 26 | — | — | ||
| Q4 25 | $-9.9M | — | ||
| Q3 25 | $15.7M | $-10.9M | ||
| Q2 25 | $-51.1M | — | ||
| Q1 25 | $-31.2M | — | ||
| Q4 24 | $-68.1M | — | ||
| Q3 24 | $-30.8M | — | ||
| Q2 24 | $3.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | -2.6% | — | ||
| Q3 25 | 3.9% | -9043.3% | ||
| Q2 25 | -13.0% | — | ||
| Q1 25 | -8.2% | — | ||
| Q4 24 | -17.6% | — | ||
| Q3 24 | -7.8% | — | ||
| Q2 24 | 0.9% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.9% | — | ||
| Q3 25 | 4.6% | 15.0% | ||
| Q2 25 | 5.8% | — | ||
| Q1 25 | 8.6% | — | ||
| Q4 24 | 8.5% | 0.0% | ||
| Q3 24 | 12.0% | 0.0% | ||
| Q2 24 | 5.3% | 0.0% |
| Q1 26 | — | — | ||
| Q4 25 | 0.13× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -10.44× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.18× | — | ||
| Q3 24 | 2.79× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
